Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 57 results for "clinigene"

Clinigen continues to perform str...

Speciality global pharmaceutical company Clinigen's first half revenues rose by 17% (21% on a constant currency basis) to £72.6m as the group continued to perform strongly, in line with the board's expectations. Gross profit was up 11%, with ... TrustNet, 2 weeks ago
Strong first half for Clinigen Insider Media Limited, 2 weeks ago
Clinigen continues to perform strongly MoneyAM, 2 weeks ago

4 images for clinigene

Mideast Time, 1 week ago
WKRB News, 2 weeks ago
Proactive Investors.co.uk, 2 weeks ago
DirectorsTalk, 2 weeks ago

N + 1 Singer retains buy on Clinigen Group, target raised from 500p to 549p

At 10:15am: (LON:ISAT) Inmarsat PLC share price was -7.5p at 826.5p Story provided
 MoneyAM1 week ago FLASH: N + 1 Singer retains buy on Clinigen Group, target raised from 500p to 549p  Stock Market Wire1 week ago
Mideast Time

N+1 Singer Reaffirms Buy Rating for Clinigen Group PLC

N+1 Singer reiterated their buy rating on shares of Clinigen Group PLC (LON:CLIN) in a research report released on Thursday morning. N+1 Singer currently has a GBX 500 ($7.57) price objective on the stock. A number of other firms have also recently ...
 Mideast Time1 week ago Clinigen Group PLC's Buy Rating Reiterated at N+1 Singer  WKRB News2 weeks ago Numis Securities Ltd Reaffirms Buy Rating for Clinigen Group PLC (LON:CLIN)  Ticker Report2 weeks ago Clinigen Group PLC's Buy Rating Reaffirmed at Numis Securities Ltd (LON:CLIN)  Mideast Time2 weeks ago
[x]  
DirectorsTalk

Peter George, the chief executive of specialty pharmaceuticals group Clinigen (LON:CLIN)

is particularly pleased with the performance of the clinical trials supply business. George adds that the group is keen to make more acquisitions that will help it grow geographically, especially in the southern hemisphere. Don't miss out on news ...
 DirectorsTalk2 weeks ago Clinigen CEO particularly pleased by clinical trials supply business  Proactive Investors.co.uk2 weeks ago

Half year trading update

Burton-on-Trent, UK - 15 January 2015 - Clinigen Group plc ('Clinigen' or the 'Group', AIM: CLIN), the specialty global pharmaceutical company, today provides a half year update for the six months ended 31 December 2014. The Group continues ...
 TrustNet2 weeks ago Clinigen Group plc Half year trading update  ADVFN UK2 weeks ago CLINIGEN : Half year trading update  4 Traders2 weeks ago
Proactive Investors.co.uk

Clinigen first half revenues up 17%, boosted by clinical trials supply arm and new products

Clinigen () said it performed strongly in the first half of its financial year as its clinical trials supply business (CTS) cemented its place as a global leader in the sector. The specialty pharma group's trading in the six months to the end of ...
 Proactive Investors.co.uk2 weeks ago UPDATE - Clinigen first half revenues up 17%, boosted by clinical trials supply arm and new products  Proactive Investors.co.uk2 weeks ago

Clinigen Revenue Rises In First Half, Confident On Full Year

LONDON (Alliance News) - Pharmaceutical company Clinigen Group PLC on Thursday said it performed in line in the first half of its financial year on improvements at its Clinical Trial Supply and Clinigen Specialty Pharmaceuticals businesses.Revenue ...
 London South East2 weeks ago Clinigen Posts 17% Rise in 1H Revenue  iMarketReports2 weeks ago CLINIGEN : Revenue Rises In First Half, Confident On Full Year  4 Traders2 weeks ago

Clinigen clinch AIM award

The awards, presented by BBC journalist Sophie Raworth , at a dinner at Old Billingsgate in association with Ford Sinclair, bring together the best of the fast growing entrepreneurial companies on AIM, both UK and internationally based. During ...
 Business Quarter1 month ago

Hybridan Lifesciences wrap:Clinigen Group, Cyprotex, Evocutis plc, Skyepharma and others

Top 5 Risers Evocutis () Following on from the disposal earlier in the year of LabSkin, SYN1113 and related assets Evocutis is now essentially a cash shell. LabSkin is a living skin equivalent model system which seeks to emulate normal human ...
 Proactive Investors.co.uk1 month ago

Half Yearly Report

Regulatory Story - HSL Released 07:00 28-Jan-2015 RNS Number : 3133D 28 January 2015  THE HENDERSON SMALLER COMPANIES INVESTMENT TRUST PLC Financial Report for the half-year ended 30 November 2014 This announcement contains regulated information ...
 London Stock Exchange3 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less